Long-term efficacy of rituximab in chronic ataxic neuropathy associated with anti-ganglioside antibodies
Mostra el registre complet Registre parcial de l'ítem
- dc.contributor.author Bertran-Recasens, Bernat
- dc.contributor.author Figueras-Aguirre, Georgina
- dc.contributor.author Royo de Mingo, I.
- dc.contributor.author Rubio Pérez, Miguel Angel
- dc.date.accessioned 2022-06-27T06:28:08Z
- dc.date.available 2022-06-27T06:28:08Z
- dc.date.issued 2021
- dc.format.mimetype application/pdf
- dc.identifier.citation Bertran Recasens B, Figueras-Aguirre G, Royo De Mingo I, Rubio MÁ. Long-term efficacy of rituximab in chronic ataxic neuropathy associated with anti-ganglioside antibodies. Neurologia (Engl Ed). 2021 Nov-Dec;36(9):739-42. DOI: 10.1016/j.nrleng.2021.02.006
- dc.identifier.doi http://dx.doi.org/10.1016/j.nrleng.2021.02.006
- dc.identifier.issn 2173-5808
- dc.identifier.uri http://hdl.handle.net/10230/53589
- dc.language.iso eng
- dc.publisher Elsevier
- dc.relation.ispartof Neurologia (Engl Ed). 2021 Nov-Dec;36(9):739-42
- dc.rights © 2021 Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Neurología. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
- dc.rights.accessRights info:eu-repo/semantics/openAccess
- dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/4.0/
- dc.title Long-term efficacy of rituximab in chronic ataxic neuropathy associated with anti-ganglioside antibodies
- dc.title.alternative Eficacia a largo plazo del rituximab en la neuropatía crónica atáxica con anticuerpos antigangliósidos
- dc.type info:eu-repo/semantics/article
- dc.type.version info:eu-repo/semantics/publishedVersion